CELG.RT

Bristol-Myers Squibb Company Contingent Value Rights
CELG.RT

Overview Fund Activity

20 hedge funds and large institutions have $88K invested in Bristol-Myers Squibb Company Contingent Value Rights in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 7 closing their positions.

Holders
20
Holders Change
-5
Holders Change %
-20%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
1
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VF
1
Virtu Financial
New York
$8K

Top Sellers

1
RIM
1
Redpoint Investment Management
Australia
$0
2
SAM
2
Selway Asset Management
$0
3
CRIG
3
Charter Research & Investment Group
Connecticut
$0
4
GGI
4
Godsey & Gibb Inc
Virginia
$0
5
DAM
5
Deltec Asset Management
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
US Bancorp
26
US Bancorp
Minnesota
$0 25 +25 New
Morgan Stanley
27
Morgan Stanley
New York
$0 105 +66 +169%
CAPTRUST Financial Advisors
28
CAPTRUST Financial Advisors
North Carolina
$0 971 +941 +3,137%
1
2